On July 14, 2026, the Australian Industrial Chemicals Introduction Scheme (AICIS), pursuant to Section 83 of the Industrial Chemicals Act 2019, formally added a polymeric chemical (CAS No. 882688-53-1) to the Australian Inventory of Industrial Chemicals (AIIC). The chemical had been assessed under a previously issued assessment certificate, and its listing on the Inventory means that enterprises may lawfully introduce (import or manufacture) it into Australia within the scope determined by the assessment certificate.
The registration information and Defined Scope of Assessment for this chemical are shown in the table below (the information is sourced from the official website) :
|
CAS Number |
882688-53-1 |
|
Chemical Name |
Phenol, 4,4′-(1-methylethylidene)bis-, polymer with N-(2-aminoethyl)-1,2-ethanediamine, N,N′-bis(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane and .alpha.-hydro-.omega.-hydroxypoly(oxy-1,2-ethanediyl), N-benzyl derivs. |
|
Molecular Formula |
Unspecified |
|
Defined Scope of Assessment |
The chemical has been assessed: - as imported into Australia at up to 50 tonnes/year - as imported as a liquid formulation containing the assessed chemical at up to 43% concentration for local reformulation into paint and coating products at up to 25% concentration for use by professional workers only. |
|
Listing date |
14 July 2026 |
ChemRadar Insights
Inventory listing is a prerequisite for the lawful introduction of industrial chemicals in Australia, but this listing carries a clearly defined assessment scope, imposing limits on the annual import volume, the formulation concentration after import and reformulation, the end use (paint and coating products), and the user group (professional workers only). Importing or manufacturing enterprises must strictly comply with this assessment scope; if they intend to use the chemical beyond this scope (for example, by increasing the concentration, extending the user group to general consumers, using it for other purposes, or increasing the import volume), they must separately apply to AICIS for an assessment or confirm the applicable compliance pathway, and must not expand the use directly.
